Horizon scanning for novel and emerging in vitro mammalian cell mutagenicity test systems

Stephen J Evans1, Bhaskar Gollapudi2, Martha M Moore3

  • 1In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea University, Singleton Park, Swansea SA2 8PP, Wales, UK.

Insights

New in vitro methods for detecting gene mutations are crucial for toxicological screening. Next-generation sequencing (NGS) shows promise for high-throughput mutagenicity testing, though further development is needed for regulatory use.

Area of Science:

  • Toxicology
  • Genetics
  • Molecular Biology

Background:

  • In vitro mutagenicity testing is essential for toxicological screening to assess potential adverse impacts on gene function.
  • Current reporter gene assays for mutagenicity are often labor-intensive and not suitable for high-throughput screening.
  • The International Workshops on Genotoxicity Testing (IWGT) identified the need for novel, efficient in vitro mammalian cell mutagenicity test systems.